Eli Lilly and Company (LLY)
NYSE · Healthcare
Eli Lilly and Company Total Liabilities 2020–2025
Eli Lilly and Company annual total liabilities history from 2020 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Eli Lilly and Company total liabilities as of December 31, 2025: 85.94B, a 33.36% increase year-over-year.
- Eli Lilly and Company total liabilities for 2025 were 85.94B, a 33.36% increase from 2024.
- Eli Lilly and Company total liabilities for 2024 were 64.44B, a 21.26% increase from 2023.
- Eli Lilly and Company total liabilities for 2023 were 53.14B, a 37.27% increase from 2022.
- Eli Lilly and Company total liabilities for 2022 were 38.71B.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Eli Lilly and Company Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $85,941 |
| 2024 | $64,443 |
| 2023 | $53,143 |
| 2022 | $38,714 |
| 2021 | $39,651 |
| 2020 | $40,808 |
Eli Lilly and Company Total Liabilities — FAQ
Eli Lilly and Company (LLY) total liabilities over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LLY's total liabilities history?
The chart and table above show Eli Lilly and Company's total liabilities by year and by quarter, including the growth rate.